Booking Holdings Inc. (LON:0W2Y)

Verve Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	131,789	131,348	97,163	64,878	72,760	66,811
Market Cap Growth	29.29%	35.18%	49.76%	-10.83%	8.90%	2.94%
Enterprise Value	132,717	132,064	97,247	63,585	70,164	67,730
Last Close Price	4053.70	3963.43	2746.03	1640.78	1754.20	1590.91
PE Ratio	37.51	27.96	28.86	25.56	84.57	1546.06
PS Ratio	7.22	6.93	5.79	4.57	8.99	13.42
PB Ratio	-27.12	-40.90	-45.10	28.10	15.95	18.64
P/TBV Ratio	-	-	-	-	79.84	76.91
P/FCF Ratio	-	20.83	17.68	12.64	39.16	-
P/OCF Ratio	-	19.76	16.85	11.93	34.94	1073.15
EV/Sales Ratio	7.02	6.97	5.80	4.48	8.67	13.61
EV/EBITDA Ratio	19.11	20.21	19.27	14.42	31.12	95.83
EV/EBIT Ratio	21.12	21.79	20.91	15.76	36.10	182.39
EV/FCF Ratio	19.68	20.94	17.70	12.39	37.76	-
Debt / Equity Ratio	-2.89	-4.29	-5.47	4.75	1.85	2.56
Debt / EBITDA Ratio	2.09	2.04	2.24	2.39	3.48	10.42
Debt / FCF Ratio	2.08	2.18	2.14	2.14	4.54	-
Asset Turnover	0.85	0.91	0.86	0.70	0.48	0.31
Quick Ratio	1.18	1.24	1.20	1.73	2.00	3.39
Current Ratio	1.25	1.31	1.28	1.86	2.11	3.56
Return on Equity (ROE)	-	-	22573.68%	68.26%	21.05%	1.09%
Return on Assets (ROA)	17.57%	18.22%	14.90%	12.40%	7.23%	1.46%
Return on Capital (ROIC)	40.58%	37.24%	26.21%	18.09%	9.39%	1.94%
Return on Capital Employed (ROCE)	69.10%	62.90%	53.80%	28.80%	15.10%	2.70%
Earnings Yield	2.67%	3.58%	3.47%	3.91%	1.18%	0.07%
FCF Yield	5.12%	4.80%	5.66%	7.91%	2.55%	-0.22%
Dividend Yield	0.52%	0.70%	-	-	-	-
Payout Ratio	25.16%	19.96%	-	-	-	-
Buyback Yield / Dilution	5.11%	6.75%	8.79%	3.17%	-0.49%	5.40%
Total Shareholder Return	5.62%	7.46%	8.79%	3.17%	-0.49%	5.40%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.